Your browser doesn't support javascript.
loading
Mucosal nanobody IgA as inhalable and affordable prophylactic and therapeutic treatment against SARS-CoV-2 and emerging variants.
Li, Qi; Humphries, Fiachra; Girardin, Roxie C; Wallace, Aaron; Ejemel, Monir; Amcheslavsky, Alla; McMahon, Conor T; Schiller, Zachary A; Ma, Zepei; Cruz, John; Dupuis, Alan P; Payne, Anne F; Maryam, Arooma; Yilmaz, Nese Kurt; McDonough, Kathleen A; Pierce, Brian G; Schiffer, Celia A; Kruse, Andrew C; Klempner, Mark S; Cavacini, Lisa A; Fitzgerald, Katherine A; Wang, Yang.
Afiliação
  • Li Q; MassBiologics, University of Massachusetts Chan Medical School, Boston, MA, United States.
  • Humphries F; Division of Innate Immunity, Department of Medicine, University of Massachusetts Chan Medical School, Worcester, MA, United States.
  • Girardin RC; Wadsworth Center, New York State Department of Health, Albany, NY, United States.
  • Wallace A; MassBiologics, University of Massachusetts Chan Medical School, Boston, MA, United States.
  • Ejemel M; MassBiologics, University of Massachusetts Chan Medical School, Boston, MA, United States.
  • Amcheslavsky A; MassBiologics, University of Massachusetts Chan Medical School, Boston, MA, United States.
  • McMahon CT; Department of Biological Chemistry and Molecular Pharmacology, Blavatnik Institute, Harvard Medical School, Boston, MA, United States.
  • Schiller ZA; MassBiologics, University of Massachusetts Chan Medical School, Boston, MA, United States.
  • Ma Z; MassBiologics, University of Massachusetts Chan Medical School, Boston, MA, United States.
  • Cruz J; Department of Pathology, University of Massachusetts Chan Medical School, Worcester, MA, United States.
  • Dupuis AP; Wadsworth Center, New York State Department of Health, Albany, NY, United States.
  • Payne AF; Wadsworth Center, New York State Department of Health, Albany, NY, United States.
  • Maryam A; Department of Biochemistry and Molecular Biotechnology, University of Massachusetts Chan Medical School, Worcester, MA, United States.
  • Yilmaz NK; Department of Biochemistry and Molecular Biotechnology, University of Massachusetts Chan Medical School, Worcester, MA, United States.
  • McDonough KA; Wadsworth Center, New York State Department of Health, Albany, NY, United States.
  • Pierce BG; Institute for Bioscience and Biotechnology Research, University of Maryland, Rockville, MD, United States.
  • Schiffer CA; Department of Biochemistry and Molecular Biotechnology, University of Massachusetts Chan Medical School, Worcester, MA, United States.
  • Kruse AC; Department of Biological Chemistry and Molecular Pharmacology, Blavatnik Institute, Harvard Medical School, Boston, MA, United States.
  • Klempner MS; MassBiologics, University of Massachusetts Chan Medical School, Boston, MA, United States.
  • Cavacini LA; MassBiologics, University of Massachusetts Chan Medical School, Boston, MA, United States.
  • Fitzgerald KA; Division of Innate Immunity, Department of Medicine, University of Massachusetts Chan Medical School, Worcester, MA, United States.
  • Wang Y; MassBiologics, University of Massachusetts Chan Medical School, Boston, MA, United States.
Front Immunol ; 13: 995412, 2022.
Article em En | MEDLINE | ID: mdl-36172366

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Imunoglobulina A / Anticorpos de Domínio Único / SARS-CoV-2 / COVID-19 Limite: Animals / Humans Idioma: En Revista: Front Immunol Ano de publicação: 2022 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Imunoglobulina A / Anticorpos de Domínio Único / SARS-CoV-2 / COVID-19 Limite: Animals / Humans Idioma: En Revista: Front Immunol Ano de publicação: 2022 Tipo de documento: Article